← Back to all earnings calls

Serina Therapeutics, Inc. Q4 FY2023 Earnings Call

Serina Therapeutics, Inc. (SER)

Earnings Call FY2023 Q4 Call date: 2024-03-22 NoCallHeld

Share

Quarter scorecard

Revenue (derived Q4)

$3.09M

+38487.5% YoY

Gross margin (derived Q4)

1.8%

-85.7 pp YoY

Net income (derived Q4)

$1.05M

Documents & deck